Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Pfizer, Amgen, and dozens of smaller biotechs are racing to develop GLP-1 alternatives
10.1056/NEJM198111053051915 75
Patients frequently report feeling intoxicated faster and from fewer drinks than they did before starting tirzepatide
Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy will have the option to buy now and pay later under a partnership announced Tuesday by telehealth provider FuturHealth and consumer finance company Affirm
In a contemporary cohort of 16,492 patients with T2D and at high/very high CV risk participating in the SAVOR-TIMI 53 trial [6], CVD remained the leading cause of death and approximately one-third of all deaths were classified as sudden
Li J, Chen JJ, Zhang F, Zhang C
US$ 22.71
US$ 25.07
US$ 25.72
US$ 21.80
US$ 29.35
